Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers and use of MET inhibitor for treatment of cancer

Biomarkers and use of MET inhibitor for treatment of cancer

US Patent 10328062 · Granted Jun 25, 2019

Estimated economic value: $457,619,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for measuring changes in cellular activity in live tissue2025
Ex vivo systems and methods for determining the effect of a drug or other agent 2025
Anti-coagulation factor XI antibody2024
Ex vivo systems and methods for determining the effect of a drug or other agent 2022
Combination therapy including an MDM2 inhibitor and one or more additional pharm2021
Combination therapy including an MDM2 inhibitor and one or more additional pharm2021
Specific binding agents to hepatocyte growth factor2013
Neural regeneration peptides and methods for their use in treatment of neural in2010
Neural regeneration peptides and methods for their use in treatment of brain dam2009